BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 32508220)

  • 1. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S; Ghanian S; Parikh SA; Secemsky EA; Schneider PA; Armstrong EJ
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
    Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
    J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
    [No Abstract]   [Full Text] [Related]  

  • 6. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.
    Giannopoulos S; Secemsky EA; Mustapha JA; Adams G; Beasley RE; Pliagas G; Armstrong EJ
    J Endovasc Ther; 2020 Oct; 27(5):714-725. PubMed ID: 32618486
    [No Abstract]   [Full Text] [Related]  

  • 7. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials.
    Anantha-Narayanan M; Shah SM; Jelani QU; Garcia S; Ionescu C; Regan C; Mena-Hurtado C
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):139-148. PubMed ID: 30838719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
    Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M;
    JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midterm Outcomes of Drug-Coated Balloon Angioplasty in Femoropopliteal Lesions in a Daily Practice Cohort.
    Nugteren M; Serné A; Verhoeven B; Koning O; van den Haak R; Scholtes V; Hinnen JW
    Ann Vasc Surg; 2020 Apr; 64():188-197. PubMed ID: 31634609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matched comparison of uncoated and paclitaxel-coated balloon angioplasty for isolated popliteal lesions excluding bail-out stenting.
    Böhme T; Noory E; Beschorner U; Bollenbacher R; Nührenberg T; Rastan A; Westermann D; Zeller T
    Cardiovasc Revasc Med; 2024 Jun; 63():54-58. PubMed ID: 38245433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherectomy plus drug-coated balloon versus drug-coated balloon only for treatment of femoropopliteal artery lesions: A systematic review and meta-analysis.
    Lin F; Wang H; Ding W; Chen G; Zhang Z
    Vascular; 2021 Dec; 29(6):883-896. PubMed ID: 33478353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of Infrapopliteal Artery Lesions (AcoArt II-BTK).
    Jia X; Zhuang B; Wang F; Gu Y; Zhang J; Lu X; Dai X; Liu Z; Bi W; Liu C; Wang S; Liistro F; Guo W
    J Endovasc Ther; 2021 Apr; 28(2):215-221. PubMed ID: 33118432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of Angioplasty With Drug-Coated Balloon for Chronic Ischemia in Wound Healing.
    Hata Y; Iida O; Ito N; Soga Y; Fukunaga M; Kawasaki D; Fujihara M; Kozuki A; Takahara M; Mano T
    J Endovasc Ther; 2021 Oct; 28(5):778-787. PubMed ID: 34152229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
    Laird JA; Schneider PA; Jaff MR; Brodmann M; Zeller T; Metzger DC; Krishnan P; Scheinert D; Micari A; Wang H; Masters M; Tepe G
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007702. PubMed ID: 31195825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries: A Meta-Analysis of Randomized Trials.
    Cassese S; Ndrepepa G; Liistro F; Fanelli F; Kufner S; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    JACC Cardiovasc Interv; 2016 May; 9(10):1072-80. PubMed ID: 27131439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.